These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26208800)

  • 1. (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
    Kim JS; Park HE; Oh YS; Song IU; Yang DW; Park JW; Lee KS
    J Neurol Sci; 2015 Oct; 357(1-2):173-7. PubMed ID: 26208800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy.
    Fujishiro H; Nakamura S; Kitazawa M; Sato K; Iseki E
    J Neurol Sci; 2012 Apr; 315(1-2):115-9. PubMed ID: 22129938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
    Yoshita M; Taki J; Yokoyama K; Noguchi-Shinohara M; Matsumoto Y; Nakajima K; Yamada M
    Neurology; 2006 Jun; 66(12):1850-4. PubMed ID: 16801649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
    Yoshita M; Taki J; Yamada M
    J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):583-8. PubMed ID: 11606666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies.
    Kobayashi S; Tateno M; Morii H; Utsumi K; Saito T
    Psychiatry Res; 2009 Oct; 174(1):76-80. PubMed ID: 19766460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
    Slaets S; Van Acker F; Versijpt J; Hauth L; Goeman J; Martin JJ; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2015 Aug; 30(8):864-9. PubMed ID: 25363642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of dementia with Lewy bodies: can
    Sakamoto F; Shiraishi S; Tsuda N; Hashimoto M; Tomiguchi S; Ikeda M; Yamashita Y
    Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study.
    Wada-Isoe K; Kitayama M; Nakaso K; Nakashima K
    J Neurol Sci; 2007 Sep; 260(1-2):33-7. PubMed ID: 17459416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging].
    Estorch M; Camacho V; Fuertes J; Rodríguez-Revuelto A; Hernández MA; Flotats A; Kulisevsky J; Carrió I
    Rev Esp Med Nucl; 2006; 25(4):229-35. PubMed ID: 16827985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Komatsu J; Samuraki M; Nakajima K; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamashina S; Yamasaki J; Yoshita M; Yamada M
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1167-1173. PubMed ID: 29853532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
    Manabe Y; Inui Y; Toyama H; Kosaka K
    Psychiatry Res Neuroimaging; 2017 Mar; 261():75-79. PubMed ID: 28152401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease.
    Watanabe H; Ieda T; Katayama T; Takeda A; Aiba I; Doyu M; Hirayama M; Sobue G
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):781-3. PubMed ID: 11385013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validity of presynaptic dopaminergic imaging with 
    Sonni I; Ratib O; Boccardi M; Picco A; Herholz K; Nobili F; Varrone A;
    Neurobiol Aging; 2017 Apr; 52():228-242. PubMed ID: 28317651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N
    Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
    Yoshita M; Arai H; Arai H; Arai T; Asada T; Fujishiro H; Hanyu H; Iizuka O; Iseki E; Kashihara K; Kosaka K; Maruno H; Mizukami K; Mizuno Y; Mori E; Nakajima K; Nakamura H; Nakano S; Nakashima K; Nishio Y; Orimo S; Samuraki M; Takahashi A; Taki J; Tokuda T; Urakami K; Utsumi K; Wada K; Washimi Y; Yamasaki J; Yamashina S; Yamada M
    PLoS One; 2015; 10(3):e0120540. PubMed ID: 25793585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.